ManagedCareCGM

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes

Return to Resources *Product Comparison AMCP Formulary Dossiers Clinical Studies Coverage and Benefit Design Featured Resources Health Economics and Outcomes Research (HEOR) Non-CE Education Resources Other Resources Professional Guidelines Real-World Evidence Review Articles
Tags:

Source: Diabetes Technology & Therapeutics

Key Takeaway: CGM initiated within the first year of T1D diagnosis was effective in lowering and maintaining A1C for 2.5 years and reduced the frequency of ED visits related to hypoglycemia and hyperglycemia irrespective of insulin delivery method.

Click here to access (full article available for a fee).

Jointly Provided by

Jointly Provided by

This activity is supported by an independent educational grant from DexCom, Inc.